Document is current
Any future updates will be listed below
-
Authors
Lebas, Héloïse
Guérit, Sylvaine
Picot, Audrey
Boulay, Anne Cécile
Fournier, Antoine
Vivien, Denis
Cohen Salmon, Martine
Docagne, Fabian
Bardou, Isabelle https://orcid.org/0000-0003-0432-3635
-
Funding
Funding for this research was provided by:
Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation
INSERM
Conseil régional de Normandie
Fondation Recherche Médicale
Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques
- License Information
-
More Information
Article History
Received: 16 December 2021
Revised: 4 April 2022
Accepted: 29 April 2022
First Online: 28 May 2022
Declarations
:
: The authors declare that they have no competing interests.
: Animal experiments were performed in accordance with French ethical laws (Decree 87/848) and European guidelines (Directive 2010/63/UE) for the care and use of laboratory animals. Experiments were undertaken in the housing and laboratories (approval #F14118001) and have been approved by the ethics committee no. 52 on animal experiments (CENOMEXA) and by the French Ministry of Research under the project license number #10799. All experiments were performed following the ARRIVE guidelines (), including randomization of treatment as well as analysis blind to the treatment.
: Not applicable.
